Tackling TKI resistance in AML: A commentary on 'Inhibition of BCL2A1 by STAT5 inactivation overcomes resistance to targeted therapies of FLT3-ITD/D835 mutant AML.' by Yamatani et al.
| Autor: | Özden Hatırnaz Ng, Ahmet Emre Eşkazan |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Translational Oncology, Vol 19, Iss , Pp 101394- (2022) |
| Druh dokumentu: | article |
| ISSN: | 1936-5233 |
| DOI: | 10.1016/j.tranon.2022.101394 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|